Different Approaches to requesting Consent for Routine data linkage in Neonatal follow-up (ACORN): protocol for a 2×2 factorial randomised trial

Introduction Routinely collected data can be linked to research data to create a rich dataset and inform practice. However, consent is normally required to link identifiable data. Reported rates of consent to data linkage for children ranged from 21% to 96%, but no studies have investigated different approaches to seeking consent for data linkage for school-age children. Methods and analysis The Approaches to Consent for Routine Data Linkage in Neonatal Follow-up (ACORN) trial is a 2×2 factorial randomised trial to assess whether, for children who participated in neonatal randomised trials (pre-hypoglycaemia Prevention with Oral Dextrose Gel (hPOD), hPOD and The Impact of Protein Intravenous Nutrition on Development in Extremely Low Birth Weight Babies (ProVIDe)) and are approached to participate in an in-person assessment at 6–7 years of age, parental consent to data linkage is higher if consent is sought (1) after the in-person assessment (delayed) or concurrently and (2) for health and education data combined or separately. The primary outcomes will be rates of consent to linkage of (1) either health or education data and (2) both health and education data. A pilot study indicates the potentially available cohort size of 2110 (80% follow-up of the neonatal trial cohorts) would be adequate to detect an absolute difference of 6%–5%–4% from a baseline consent rate of 70%–85%–90%, respectively (2-tailed alpha 0.05, 90% power). With at least 1136 participants, the ACORN trial would have 90% power to detect an absolute difference of 5% in the primary outcome for each factor, assuming a consent rate of 90% in the control groups and alpha 0.05. Data are categorical and will be presented as number and per cent. The effects of factors will be tested using generalised linear models and presented as ORs and 95% CIs. Ethics and dissemination Ethics approval by the New Zealand Health and Disability Ethics Committee (19/STH/202). Dissemination will be via peer-reviewed publications, scientific meetings, educational sessions and public fora. Trial registration number ACTRN12621000571875 (Australian New Zealand Clinical Trials Registry).

[1]  G. Gamble,et al.  Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): A multicenter, double-blind randomized controlled trial , 2021, PLoS medicine.

[2]  G. Moore,et al.  Sources of potential bias when combining routine data linkage and a national survey of secondary school-aged children: a record linkage study , 2020, BMC Medical Research Methodology.

[3]  L. Ohno-Machado,et al.  Patient Perspectives About Decisions to Share Medical Data and Biospecimens for Research , 2019, JAMA network open.

[4]  K. Suzuki The developing world of DOHaD , 2017, Journal of Developmental Origins of Health and Disease.

[5]  C. Mckinlay,et al.  Mid-Childhood Bone Mass After Exposure to Repeat Doses of Antenatal Glucocorticoids: A Randomized Trial , 2017, Pediatrics.

[6]  M. Apperley,et al.  He Whare Hangarau Māori Language, culture & technology , 2017 .

[7]  L. Doyle,et al.  Mid-Childhood Outcomes of Repeat Antenatal Corticosteroids: A Randomized Controlled Trial , 2016, Pediatrics.

[8]  G. Gamble,et al.  Prophylactic Oral Dextrose Gel for Newborn Babies at Risk of Neonatal Hypoglycaemia: A Randomised Controlled Dose-Finding Trial (the Pre-hPOD Study) , 2016, PLoS medicine.

[9]  L. Straker,et al.  Data linkage in an established longitudinal cohort: the Western Australian Pregnancy Cohort (Raine) Study. , 2016, Public health research & practice.

[10]  T. Baghal Obtaining data linkage consent for children: factors influencing outcomes and potential biases , 2016 .

[11]  Leo Anthony Celi,et al.  Challenges and Opportunities in Secondary Analyses of Electronic Health Record Data , 2016 .

[12]  L. Doyle,et al.  The cost of long‐term follow‐up of high‐risk infants for research studies , 2015, Journal of paediatrics and child health.

[13]  Yannan Jiang,et al.  The ProVIDe study: the impact of protein intravenous nutrition on development in extremely low birthweight babies , 2015, BMC Pediatrics.

[14]  C. Mckinlay,et al.  Cardiovascular Risk Factors in Children After Repeat Doses of Antenatal Glucocorticoids: An RCT , 2015, Pediatrics.

[15]  Emanuela Sala,et al.  Propensity to consent to data linkage: experimental evidence on the role of three survey design features in a UK longitudinal panel , 2014 .

[16]  A. Braunack-Mayer,et al.  A randomised controlled trial to compare opt-in and opt-out parental consent for childhood vaccine safety surveillance using data linkage , 2012, Journal of Medical Ethics.

[17]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[18]  Melissa C Brouwers,et al.  Written informed consent and selection bias in observational studies using medical records: systematic review , 2009, BMJ : British Medical Journal.

[19]  A. J. Bass,et al.  A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. , 2008, Australian health review : a publication of the Australian Hospital Association.

[20]  Kent L Thornburg,et al.  Effect of in Utero and Early-life Conditions on Adult Health and Disease Epidemiol Ogic a Nd Clinic a L Observations , 2022 .

[21]  L. Doyle,et al.  Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. , 2007, The New England journal of medicine.

[22]  L. Calderwood,et al.  Mother's consent to linkage of survey data with her child's birth records in a multi-ethnic national cohort study. , 2006, International journal of epidemiology.

[23]  A. Rodgers,et al.  Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial , 2005, BMJ : British Medical Journal.

[24]  A. Rodgers,et al.  Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial , 2005, The Lancet.

[25]  P. O'Brien,et al.  A multiple testing procedure for clinical trials. , 1979, Biometrics.